Maintaining treatment with CDK4/6 inhibitors significantly suppresses the growth of breast cancer cells, even after drug resistance has developed, according to new research.

The Food and Drug Administration (FDA) has approved Datroway ® (datopotamab deruxtecan-dlnk) for the treatment of adult patients with unresectable or metastatic, hormone receptor (HR)-positive, human ...

Thousands of women who have had breast cancer feel “forgotten” as they are paying up to €102 a month for menopause treatments ...

Debate over labeling certain cancers as 'benign' or 'premalignant' instead of 'cancer' due to stigma and fear. Experts weigh in on potential impact ...

A retired NHS nurse has become the first patient to undergo “awake” breast surgery at the Midland Metropolitan University ...

Discussions also delved into the complexities of value-based oncology care, the growing role of real-world data, and strategies to improve access to care in hematology. Across all sessions, a common ...

A new study has found a way to treat patients with triple-negative breast cancer using a shorter and less toxic treatment plan while achieving similar results to the current standard. The study, ...

Roche said on Thursday it is targeting a continued increase in adjusted earnings per share (EPS) at a high single-digit ...

An injectable hydrogel platform shows promise in local immunotherapy for triple-negative breast cancer, enhancing treatment ...

Noelyn Patricio Arzaga, a domestic worker from the Philippines, said her employer fired her after she decided to undergo ...

Discover why Exact Sciences, a leading oncology diagnostics company, may see growth in the cancer diagnostics market with its ...

Ypsilon Therapeutics, a portfolio company of 82VS, Alloy's venture studio, has been awarded $2.7 million in seed funding from CPRIT. Ypsilon will use the grant to rapidly advance its lead therapeutic ...